ici 118551 has been researched along with Invasiveness, Neoplasm in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hu, HT; Ma, QY; Zhang, D; Zhang, M | 1 |
1 other study(ies) available for ici 118551 and Invasiveness, Neoplasm
Article | Year |
---|---|
β2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NFκB and AP-1.
Topics: Adrenergic beta-2 Receptor Antagonists; Animals; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cyclic AMP Response Element-Binding Protein; Cyclooxygenase 2; Electrophoretic Mobility Shift Assay; Enzyme-Linked Immunosorbent Assay; Humans; Matrix Metalloproteinase 2; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; NF-kappa B; Pancreatic Neoplasms; Propanolamines; Receptors, Adrenergic, beta; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factor AP-1; Vascular Endothelial Growth Factor A | 2010 |